Dr. Reddy’s launched its authorized generic version of VASOSTRICT

0 70

Dr. Reddy’s Laboratories Ltd. stated on Wednesday that its authorized generic version of Par Pharmaceutical’s VASOSTRICT (vasopressin injectable, USP) Vials has been approved by the US Food and Drug Administration for sale in the US market (USFDA).

“We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19. The VASOSTRICT brand market had U.S. sales of approximately $878.5 million MAT for the most recent twelve months ending in December 2021 according to IQVIA Health,*

says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories Inc.

Dr. Reddy’s Vasopressin Injection, USP comes in a carton of 25 single-dose vials, each containing 1 mL of vasopressin at a concentration of 20 units per milliliter.

Leave A Reply

Your email address will not be published.